Global Prenatal and Newborn Genetic Testing
Market Report
2025
Prenatal and Newborn Genetic Testing Market Report 2025 (Global Edition)
As per Cognitive Market Research's latest published report, the Global Prenatal and Newborn Genetic Testing market size was $4.91 Billion in 2022 and it is forecasted to reach $13.76 Billion by 2030. The prenatal and Newborn Genetic Testing Industry's Compound Annual Growth Rate will be 10.51% from 2023 to 2030.
The base year for the calculation is 2023 and 2019 to 2023 will be historical period. The year 2024 will be estimated one while the forecasted data will be from year 2025 to 2031. When we deliver the report that time we updated report data till the purchase date.
PDF Access: Password protected PDF file, Excel File Access: Quantitative data, PPT Report Access: For the presentation purpose, Cloud Access: Secure Company Account Access.
| Share your contact details to receive free updated sample copy/pages of the recently published edition of Prenatal and Newborn Genetic Testing Market Report 2024.
Global Prenatal and Newborn Genetic Testing Market Report 2024 Market Size Split by Product Type (Consumables, Instruments), by End User (Hospitals, Diagnostic Organization, Maternity and Specialty Cl...
As per Cognitive Market Research's latest published report, the Global Prenatal and Newborn Genetic Testing market size was $4.91 Billion in 2022 and it is forecasted to reach $13.76 Billion by 2030. The Prenatal and Newborn Genetic Testing Industry's Compound Annual Growth Rate will be 10.51% from 2023 to 2030.
| Base Year | 2023 |
| Historical Data Time Period | 2019-2023 |
| Forecast Period | 2024-2031 |
| Global Prenatal and Newborn Genetic Testing Market Compound Annual Growth Rate (CAGR) for 2024 to 2031 | 10.51% |
| Market Split by Product Type |
|
| Market Split by End User |
|
| Market Split by Screening |
|
| Market Split by Disease |
|
| List of Competitors |
|
| Regional Analysis |
|
Country Analysis |
|
Report scope is customizable as we have a huge database of Prenatal and Newborn Genetic Testing industry. We can deliver an exclusive report Edition/Consultation as per your data requirements. Request for your Free Sample Pages.
Prenatal and Newborn Genetic Testing Market is Segmented as below. Particular segment of your interest can be provided without any additional cost. Download the Sample Pages!
Prenatal and Newborn Genetic Testing Market Report Description
What is Prenatal and Newborn Genetic Testing?
Prenatal testing provides information about the baby’s health. This test detects any problems which affect the health of fetuses like genetic defects and congenital conditions. Newborn testing detects abnormalities that can cause certain health conditions such as inborn genetic defects. In addition, the genetic diseases detected in newborns during screening are Down syndrome, phenylketonuria, homocystinuria, and others.
Prenatal and Newborn Genetic Testing Market Size
Factors Impacting on Prenatal and Newborn Genetic Testing Market
The increasing prevalence of congenital malformations and genetic abnormalities and the demand for non-invasive prenatal screening is expected to drive the growth of the prenatal and newborn genetic testing market. In addition, increasing awareness about prenatal and newborn genetic testing, and adoption of novel diagnostic methods for screening is the key factor expected to drive the growth of the target market. Furthermore, increasing research and development investment in the discovery & development of novel screening methods and the number of women with advanced maternal age. This is expected to create growth opportunities for the prenatal and newborn genetic testing market. However, the increasing cost of screening methods and the chances of miscarriage due to some prenatal testing hamper the growth of the prenatal and newborn genetic testing market.
We have various report editions of Prenatal and Newborn Genetic Testing Market, hence please contact our sales team and author directly to obtain/purchase a desired Edition eg, Global Edition, Regional Edition, Country Specific Report Edition, Company Profiles, Forecast Edition, etc. Request for your Free Sample PDF/Online Access.
Prenatal and Newborn Genetic Testing Market Insights Video
Top Companies in Prenatal and Newborn Genetic Testing Market
Competitive Landscape includes company profiling of the key manufacturers listed below. It also provides the key developments such as new product launches, expansion, mergers & acquisitions, partnerships, agreements, joint ventures, business overview, key strategies and financial analysis associated with the key players. Strategy implemented to overcome the COVID-19 Impact will be discussed in the report scope. Key players Financials includes Revenue (USD Million), Gross Margin (%) and Market Share (%) (2019- 2023), S.W.O.T Analysis, (To read more request the sample pages Or speak to analyst/author directly).
Top Companies Market Share in Prenatal and Newborn Genetic Testing Industry: (In no particular order of Rank)
- Roche Diagnostic
- Elitech Group
- Myriad Genetics
- Biocartis
- IntegraGen
- Perkin Elmer
- WaferGen Biosystem
- Interpace Diagnostics
- Quest Diagnostic
- Bio-Rad
- AutoGenomics
- Abbott
- Cepheid
- EKF Diagnostics
- Natera
- Agilent Technologies
- Illumina
- Ariosa Diagnostics
- Sequenom
- Confidential Data
- Access The Paid Version
- Data Hidden
If any Company(ies) of your interest has/have not been disclosed in the above list then please let us know the same so that we will check the data availability in our database and provide you the confirmation or include it in the final deliverables.
North America Prenatal and Newborn Genetic Testing Market accounted for the largest share!
North America has the largest revenue share in the prenatal and newborn genetic testing market. This is due to the increasing pregnancy rate, and the availability of well-developed healthcare infrastructure in the region.
The current report Scope analyzes Prenatal and Newborn Genetic Testing Market on 5 major region Split (In case you wish to acquire a specific region edition (more granular data) or any country Edition data then please write us on info@cognitivemarketresearch.com
- North America (United States, Canada, Mexico)
- Europe (United Kingdom, France, Germany, Italy, Russia, Spain, Sweden, Denmark, Netherlands, Switzerland, Belgium)
- Asia-Pacific (China, Japan, Korea, India, Australia, Philippines, Singapore, Malaysia, Thailand, Indonesia, Rest of APAC)
- South America (Brazil, Argentina, Colombia, Peru, Chile, Rest of South America)
- Middle East and Africa (Saudi Arabia, Turkey, Nigeria, UAE, Egypt, South Africa, GCC Countries, Rest of MEA)
Prenatal and Newborn Genetic Testing Market Share (%) by Region (2019-2031)
The above graph is for illustrative purposes only.
To learn more about geographical trends request the free sample pages.
Get Free Sample
Prenatal and Newborn Genetic Testing Market Analysis
Global Prenatal and Newborn Genetic Testing Market Report 2024 Edition talks about crucial market insights with the help of segments and sub-segments analysis. In this section, we reveal an in-depth analysis of the key factors influencing Prenatal and Newborn Genetic Testing Industry growth. Prenatal and Newborn Genetic Testing market has been segmented with the help of its Product Type, End User Screening, and others. Prenatal and Newborn Genetic Testing market analysis helps to understand key industry segments, and their global, regional, and country-level insights. Furthermore, this analysis also provides information pertaining to segments that are going to be most lucrative in the near future and their expected growth rate and future market opportunities. The report also provides detailed insights into factors responsible for the positive or negative growth of each industry segment.
By Product Type, the Consumables segment has the largest revenue share of Prenatal and Newborn Genetic Testing Market!
Based on product type, the consumables segment has the largest revenue share in the prenatal and newborn genetic testing market. This is due to increasing the number of pregnant women and newborns screening for genetic testing globally projected to drive the growth of this segment.
- Consumables
- Instruments
Prenatal and Newborn Genetic Testing Market Share (%) by Product Type in 2019-2031
The above Chart is for representative purposes and does not depict actual sale statistics. Access/Request the quantitative data to understand the trends and dominating segment of Prenatal and Newborn Genetic Testing Industry. Request a Free Sample PDF!
By End User, the Hospitals segment has the largest revenue share of Prenatal and Newborn Genetic Testing Market!
Based on end-user, the hospital segment has the largest revenue share in the prenatal and newborn genetic testing market. This is due to the increasing number of hospitals and the number of patients undergoing screening from hospital facilities.
- Hospitals
- Diagnostic Organization
- Maternity and Specialty Clinics
- Other
Prenatal and Newborn Genetic Testing Market Share (%) by End User in 2019-2031
2019
2023
2031
The above Graph is for representation purposes only. This chart does not depict actual Market share.
To learn more about market share request the free sample pages.
Get Free Sample
Prenatal and Newborn Genetic Testing Screening Segment Analysis
Based on screening, the non-invasive prenatal testing segment has the largest revenue share in the prenatal and newborn genetic testing market. This is due to increasing noninvasive prenatal tests to detect genetic disorders expected to drive the growth of this segment.
- Non-invasive Prenatal Testing
- Chronic Villus Sampling
- Amniocentesis
- Maternal Serum Screening
- Others
Prenatal and Newborn Genetic Testing Disease Segment Analysis
Based on disease, the Down syndrome segment has the largest revenue share in the prenatal and newborn genetic testing market. This is attributed to the increasing number of newborn babies suffering from Down syndrome due to the increasing use of newborn genetic testing and augments.
- Downs Syndrome
- Phenylketonuria
- Cystic Fibrosis
- Sickle Cell Anemia
- Others
Author's Detail
Manjiri KanhereSenior Research Associate at Cognitive Market Research
Manjiri Kanhere is an experienced market researcher focused on the Pharma & Healthcare industry. With over 3+ years of experience, She has worked with major pharmaceutical companies and healthcare providers, helping them to understand market trends, identify new business opportunities, and develop effective sales & marketing strategies. Her expertise lies in the ability to analyze complex data sets and deliver insights that drive business decisions. At Cognitive Market Research, she handles the market research related to Pharma and healthcare industry.
Manjiri Kanhere is an experienced market researcher focused on the Pharma & Healthcare industry. With over three years of experience, She has worked with major pharmaceutical companies and healthcare providers, helping them to understand market trends, identify new business opportunities, and develop effective sales & marketing strategies.
In her current role, Manjiri handles the market research related to Pharma and healthcare industry. Her passion lies in utilizing innovative approaches to distill complex information into strategic insights that empower organizations to make informed decisions.Manjiri remains an invaluable asset in the dynamic landscape of market research.
Author's Conclusion
Our study will explain complete manufacturing process along with major raw materials required to manufacture end-product. This report helps to make effective decisions determining product position and will assist you to understand opportunities and threats around the globe.
The Global Prenatal and Newborn Genetic Testing Market is witnessing significant growth in the near future.
In 2023, the Consumables segment accounted for noticeable share of global Prenatal and Newborn Genetic Testing Market and is projected to experience significant growth in the near future.
The Hospitals segment is expected to expand at the significant CAGR retaining position throughout the forecast period.
Some of the key companies Roche Diagnostic, Myriad Genetics and others are focusing on its strategy building model to strengthen its product portfolio and expand its business in the global market.
Frequently Asked Questions
Please note, we have not disclose, all the sources consulted/referred during a market study due to confidentiality and paid service concern. However, rest assured that upon purchasing the service or paid report version, we will release the comprehensive list of sources along with the complete report and we also provide the data support where you can intract with the team of analysts who worked on the report.
Latest News about Prenatal and Newborn Genetic Testing Market
Sources from Pharma & Healthcare Industry
- https://en.wikipedia.org/wiki/American_Society_for_Pharmacy_Law
- https://en.wikipedia.org/wiki/American_Society_of_Consultant_Pharmacists
- https://en.wikipedia.org/wiki/American_Society_of_Health-System_Pharmacists
- https://www.apsm-uk.com/
- https://en.wikipedia.org/wiki/Australasian_College_of_Pharmacy
- https://en.wikipedia.org/wiki/American_Association_of_Colleges_of_Pharmacy
- https://en.wikipedia.org/wiki/American_College_of_Clinical_Pharmacy
- https://en.wikipedia.org/wiki/American_Pharmacists_Association
- https://www.bio.org/
- https://en.wikipedia.org/wiki/Canadian_Pharmacists_Association
- https://en.wikipedia.org/wiki/Canadian_Society_of_Hospital_Pharmacists
- https://en.wikipedia.org/wiki/Chinese_Pharmaceutical_Association
- https://en.wikipedia.org/wiki/American_Association_of_Psychiatric_Pharmacists
- https://en.wikipedia.org/wiki/Danish_Association_of_Pharmaconomists
- https://en.wikipedia.org/wiki/EPhEU
- https://www.fda.gov/
- https://www.gmc-uk.org/
- https://www.ifpma.org/
- https://www.fip.org/
- https://en.wikipedia.org/wiki/International_Pharmaceutical_Students%27_Federation
- https://www.gov.uk/government/organisations/medicines-and-healthcare-products-regulatory-agency
- https://en.wikipedia.org/wiki/National_Pharmacy_Association
- https://en.wikipedia.org/wiki/Norwegian_Pharmacy_Association
- https://en.wikipedia.org/wiki/Canadian_Pharmacists_Journal#History
- https://en.wikipedia.org/wiki/Pakistan_Pharmacists_Association
- https://en.wikipedia.org/wiki/Pharmaceutical_Association_of_Mauritius
- https://en.wikipedia.org/wiki/Pharmaceutical_Group_of_the_European_Union
- https://en.wikipedia.org/wiki/Pharmaceutical_Society_of_Australia
- https://en.wikipedia.org/wiki/Pharmaceutical_Society_of_New_Zealand
- https://en.wikipedia.org/wiki/Pharmaceutical_Society_of_Northern_Ireland
- https://en.wikipedia.org/wiki/Professional_Compounding_Centers_of_America
- https://en.wikipedia.org/wiki/Royal_Pharmaceutical_Society
- https://www.aaps.org/home
- https://www.bioindustry.org/
- https://www.controlledreleasesociety.org/
- https://www.efpia.eu/
- https://www.epemed.org/online/www/content/ENG/index.html
- https://icr-global.org/
- https://ispe.org/
- https://en.wikipedia.org/wiki/Pharmaceutical_Association_of_Israel
- https://www.phrma.org/
- https://en.wikipedia.org/wiki/The_Pharmacy_Guild_of_Australia
- https://en.wikipedia.org/wiki/The_Society_of_Hospital_Pharmacists_of_Australia
- https://en.wikipedia.org/wiki/Healthcare_industry
- https://www.pharma-iq.com/business-development/articles/top-50-pharmaceutical-blogs-and-publications
- https://www.pharmatimes.com/news
- https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7967517/
- https://www.cbo.gov/publication/57126
- http://: https://www.who.int/tools/atc-ddd-toolkit/data
- https://www.oecd.org/els/health-systems/health-data.htm
- https://www.bls.gov/ooh/healthcare/home.htm
- https://data.worldbank.org/topic/8
- https://www.statnews.com/about/
- https://www.health.pa.gov/topics/HealthStatistics/Pages/health-statistics.aspx
- https://www.cdc.gov/nchs/index.htm
- https://www.aha.org/statistics/fast-facts-us-hospitals
- https://www.census.gov/library/publications/2021/demo/p60-274.html
- https://www.adb.org/what-we-do/sectors/health/main
Prenatal and Newborn Genetic Testing Market Report Table of Content
Disclaimer:
- This is just a redacted sample pages of the actual deliverable report and only for representative purposes
- Charts/Graphs/Numbers/data are only for Representative purposes and do not depict actual statistics.
- The table of Contents differs according to the user License selection. Current Displayed TOC is for the Corporate User License Report Edition. TOC Customization options: Add or Remove section/s Or chapter/s from the report.
- Specific Tables, Graphs, Sections, and Chapters can be ordered at a discounted price.
- If applicable; On Request Volume Data will also be provided (at an Additional Cost).
| Product Type | Consumables, Instruments |
| End User | Hospitals, Diagnostic Organization, Maternity and Specialty Clinics, Other |
| Screening | Non-invasive Prenatal Testing, Chronic Villus Sampling, Amniocentesis, Maternal Serum Screening, Others |
| Disease | Downs Syndrome, Phenylketonuria, Cystic Fibrosis, Sickle Cell Anemia, Others |
| List of Competitors | Roche Diagnostic, Elitech Group, Myriad Genetics, Biocartis, IntegraGen, Perkin Elmer, WaferGen Biosystem, Interpace Diagnostics, Quest Diagnostic, Bio-Rad, AutoGenomics, Abbott, Cepheid, EKF Diagnostics, Natera, Agilent Technologies, Illumina, Ariosa Diagnostics, Sequenom |
This chapter will help you gain GLOBAL Market Analysis of Prenatal and Newborn Genetic Testing. Further deep in this chapter, you will be able to review Global Prenatal and Newborn Genetic Testing Market Split by various segments and Geographical Split.
Chapter 1 Global Market Analysis
-
1.1 Global Prenatal and Newborn Genetic Testing Revenue Market Size, Trend Analysis 2019 - 2031
-
1.2 Global Prenatal and Newborn Genetic Testing Market Size By Regions 2019 - 2031
Global Market has been segmented on the basis 5 major regions such as North America, Europe, Asia-Pacific, Middle East & Africa, and Latin America.
-
1.2.1 Global Prenatal and Newborn Genetic Testing Revenue Market Size By Region
-
-
1.3 Global Prenatal and Newborn Genetic Testing Market Size By Product Type 2019 -2031
-
1.3.1 Consumables Market Size
-
1.3.2 Instruments Market Size
-
-
1.4 Global Prenatal and Newborn Genetic Testing Market Size By End User 2019 -2031
-
1.4.1 Hospitals Market Size
-
1.4.2 Diagnostic Organization Market Size
-
1.4.3 Maternity and Specialty Clinics Market Size
-
1.4.4 Other Market Size
-
-
1.5 Global Prenatal and Newborn Genetic Testing Market Size By Screening 2019 -2031
-
1.5.1 Non-invasive Prenatal Testing Market Size
-
1.5.2 Chronic Villus Sampling Market Size
-
1.5.3 Amniocentesis Market Size
-
1.5.4 Maternal Serum Screening Market Size
-
1.5.5 Others Market Size
-
-
1.6 Global Prenatal and Newborn Genetic Testing Market Size By Disease for 2019 -2031
-
1.6.1 Downs Syndrome Market Size
-
1.6.2 Phenylketonuria Market Size
-
1.6.3 Cystic Fibrosis Market Size
-
1.6.4 Sickle Cell Anemia Market Size
-
1.6.5 Others Market Size
-
-
1.7 Global Level Competitor Analysis (Subject to Data Availability (Private Players))
-
1.8 Executive Summary Global Market (2019 vs 2024 vs 2031)
You can purchase only the Executive Summary of Global Market (2019 vs 2024 vs 2031)
-
1.8.1 Regional Market Revenue Summary 2019 vs 2024 vs 2031
-
1.8.2 Global Market Revenue Split By Product Type
-
1.8.3 Global Market Revenue Split By End User
-
1.8.4 Global Market Revenue Split By Screening
-
1.8.5 Global Market Revenue Split By Disease
-
1.8.6 Global Market Dynamics, Trends, Drivers, Restraints, Opportunities
Global Market Dynamics, Trends, Drivers, Restraints, Opportunities, Only Pointers will be deliverable
-
This chapter will help you gain North America Market Analysis of Prenatal and Newborn Genetic Testing. Further deep in this chapter, you will be able to review North America Prenatal and Newborn Genetic Testing Market Split by various segments and Country Split.
Chapter 2 North America Market Analysis
-
2.1 North America Prenatal and Newborn Genetic Testing Market Size 2019 - 2031
-
2.1.1 North America Prenatal and Newborn Genetic Testing Market Size By Country 2019 - 2031
-
2.1.2 North America Prenatal and Newborn Genetic Testing Market Size by Product Type 2019 -2031
-
2.1.2.1 North America Consumables Market Size
-
2.1.2.2 North America Instruments Market Size
-
-
2.1.3 North America Prenatal and Newborn Genetic Testing Market Size by End User 2019 -2031
-
2.1.3.1 North America Hospitals Market Size
-
2.1.3.2 North America Diagnostic Organization Market Size
-
2.1.3.3 North America Maternity and Specialty Clinics Market Size
-
2.1.3.4 North America Other Market Size
-
-
2.1.4 North America Prenatal and Newborn Genetic Testing Market Size by Screening 2019 -2031
-
2.1.4.1 North America Non-invasive Prenatal Testing Market Size
-
2.1.4.2 North America Chronic Villus Sampling Market Size
-
2.1.4.3 North America Amniocentesis Market Size
-
2.1.4.4 North America Maternal Serum Screening Market Size
-
2.1.4.5 North America Others Market Size
-
-
2.1.5 North America Prenatal and Newborn Genetic Testing Market Size by Disease 2019 -2031
-
2.1.5.1 North America Downs Syndrome Market Size
-
2.1.5.2 North America Phenylketonuria Market Size
-
2.1.5.3 North America Cystic Fibrosis Market Size
-
2.1.5.4 North America Sickle Cell Anemia Market Size
-
2.1.5.5 North America Others Market Size
-
-
This chapter will help you gain Europe Market Analysis of Prenatal and Newborn Genetic Testing. Further deep in this chapter, you will be able to review Europe Prenatal and Newborn Genetic Testing Market Split by various segments and Country Split.
Chapter 3 Europe Market Analysis
-
3.1 Europe Prenatal and Newborn Genetic Testing Market Size 2019 - 2031
-
3.1.1 Europe Prenatal and Newborn Genetic Testing Market Size By Country 2019 - 2031
-
3.1.2 Europe Prenatal and Newborn Genetic Testing Market Size by Product Type 2019 -2031
-
3.1.2.1 Europe Consumables Market Size
-
3.1.2.2 Europe Instruments Market Size
-
-
3.1.3 Europe Prenatal and Newborn Genetic Testing Market Size by End User 2019 -2031
-
3.1.3.1 Europe Hospitals Market Size
-
3.1.3.2 Europe Diagnostic Organization Market Size
-
3.1.3.3 Europe Maternity and Specialty Clinics Market Size
-
3.1.3.4 Europe Other Market Size
-
-
3.1.4 Europe Prenatal and Newborn Genetic Testing Market Size by Screening 2019 -2031
-
3.1.4.1 Europe Non-invasive Prenatal Testing Market Size
-
3.1.4.2 Europe Chronic Villus Sampling Market Size
-
3.1.4.3 Europe Amniocentesis Market Size
-
3.1.4.4 Europe Maternal Serum Screening Market Size
-
3.1.4.5 Europe Others Market Size
-
-
3.1.5 Europe Prenatal and Newborn Genetic Testing Market Size by Disease 2019 -2031
-
3.1.5.1 Europe Downs Syndrome Market Size
-
3.1.5.2 Europe Phenylketonuria Market Size
-
3.1.5.3 Europe Cystic Fibrosis Market Size
-
3.1.5.4 Europe Sickle Cell Anemia Market Size
-
3.1.5.5 Europe Others Market Size
-
-
This chapter will help you gain Asia Pacific Market Analysis of Prenatal and Newborn Genetic Testing. Further deep in this chapter, you will be able to review Asia Pacific Prenatal and Newborn Genetic Testing Market Split by various segments and Country Split.
Chapter 4 Asia Pacific Market Analysis
-
4.1 Asia Pacific Prenatal and Newborn Genetic Testing Market Size 2019 - 2031
-
4.1.1 Asia Pacific Prenatal and Newborn Genetic Testing Market Size By Country 2019 - 2031
-
4.1.2 Asia Pacific Prenatal and Newborn Genetic Testing Market Size by Product Type 2019 -2031
-
4.1.2.1 Asia Pacific Consumables Market Size
-
4.1.2.2 Asia Pacific Instruments Market Size
-
-
4.1.3 Asia Pacific Prenatal and Newborn Genetic Testing Market Size by End User 2019 -2031
-
4.1.3.1 Asia Pacific Hospitals Market Size
-
4.1.3.2 Asia Pacific Diagnostic Organization Market Size
-
4.1.3.3 Asia Pacific Maternity and Specialty Clinics Market Size
-
4.1.3.4 Asia Pacific Other Market Size
-
-
4.1.4 Asia Pacific Prenatal and Newborn Genetic Testing Market Size by Screening 2019 -2031
-
4.1.4.1 Asia Pacific Non-invasive Prenatal Testing Market Size
-
4.1.4.2 Asia Pacific Chronic Villus Sampling Market Size
-
4.1.4.3 Asia Pacific Amniocentesis Market Size
-
4.1.4.4 Asia Pacific Maternal Serum Screening Market Size
-
4.1.4.5 Asia Pacific Others Market Size
-
-
4.1.5 Asia Pacific Prenatal and Newborn Genetic Testing Market Size by Disease 2019 -2031
-
4.1.5.1 Asia Pacific Downs Syndrome Market Size
-
4.1.5.2 Asia Pacific Phenylketonuria Market Size
-
4.1.5.3 Asia Pacific Cystic Fibrosis Market Size
-
4.1.5.4 Asia Pacific Sickle Cell Anemia Market Size
-
4.1.5.5 Asia Pacific Others Market Size
-
-
This chapter will help you gain South America Market Analysis of Prenatal and Newborn Genetic Testing. Further deep in this chapter, you will be able to review South America Prenatal and Newborn Genetic Testing Market Split by various segments and Country Split.
Chapter 5 South America Market Analysis
-
5.1 South America Prenatal and Newborn Genetic Testing Market Size 2019 - 2031
-
5.1.1 South America Prenatal and Newborn Genetic Testing Market Size By Country 2019 - 2031
-
5.1.2 South America Prenatal and Newborn Genetic Testing Market Size by Product Type 2019 -2031
-
5.1.2.1 South America Consumables Market Size
-
5.1.2.2 South America Instruments Market Size
-
-
5.1.3 South America Prenatal and Newborn Genetic Testing Market Size by End User 2019 -2031
-
5.1.3.1 South America Hospitals Market Size
-
5.1.3.2 South America Diagnostic Organization Market Size
-
5.1.3.3 South America Maternity and Specialty Clinics Market Size
-
5.1.3.4 South America Other Market Size
-
-
5.1.4 South America Prenatal and Newborn Genetic Testing Market Size by Screening 2019 -2031
-
5.1.4.1 South America Non-invasive Prenatal Testing Market Size
-
5.1.4.2 South America Chronic Villus Sampling Market Size
-
5.1.4.3 South America Amniocentesis Market Size
-
5.1.4.4 South America Maternal Serum Screening Market Size
-
5.1.4.5 South America Others Market Size
-
-
5.1.5 South America Prenatal and Newborn Genetic Testing Market Size by Disease 2019 -2031
-
5.1.5.1 South America Downs Syndrome Market Size
-
5.1.5.2 South America Phenylketonuria Market Size
-
5.1.5.3 South America Cystic Fibrosis Market Size
-
5.1.5.4 South America Sickle Cell Anemia Market Size
-
5.1.5.5 South America Others Market Size
-
-
This chapter will help you gain Middle East and Africa Market Analysis of Prenatal and Newborn Genetic Testing. Further deep in this chapter, you will be able to review Middle East and Africa Prenatal and Newborn Genetic Testing Market Split by various segments and Country Split.
Chapter 6 Middle East and Africa Market Analysis
-
6.1 Middle East and Africa Prenatal and Newborn Genetic Testing Market Size 2019 - 2031
-
6.1.1 Middle East and Africa Prenatal and Newborn Genetic Testing Market Size By Country 2019 - 2031
-
6.1.2 Middle East and Africa Prenatal and Newborn Genetic Testing Market Size by Product Type 2019 -2031
-
6.1.2.1 Middle East and Africa Consumables Market Size
-
6.1.2.2 Middle East and Africa Instruments Market Size
-
-
6.1.3 Middle East and Africa Prenatal and Newborn Genetic Testing Market Size by End User 2019 -2031
-
6.1.3.1 Middle East and Africa Hospitals Market Size
-
6.1.3.2 Middle East and Africa Diagnostic Organization Market Size
-
6.1.3.3 Middle East and Africa Maternity and Specialty Clinics Market Size
-
6.1.3.4 Middle East and Africa Other Market Size
-
-
6.1.4 Middle East and Africa Prenatal and Newborn Genetic Testing Market Size by Screening 2019 -2031
-
6.1.4.1 Middle East and Africa Non-invasive Prenatal Testing Market Size
-
6.1.4.2 Middle East and Africa Chronic Villus Sampling Market Size
-
6.1.4.3 Middle East and Africa Amniocentesis Market Size
-
6.1.4.4 Middle East and Africa Maternal Serum Screening Market Size
-
6.1.4.5 Middle East and Africa Others Market Size
-
-
6.1.5 Middle East and Africa Prenatal and Newborn Genetic Testing Market Size by Disease 2019 -2031
-
6.1.5.1 Middle East and Africa Downs Syndrome Market Size
-
6.1.5.2 Middle East and Africa Phenylketonuria Market Size
-
6.1.5.3 Middle East and Africa Cystic Fibrosis Market Size
-
6.1.5.4 Middle East and Africa Sickle Cell Anemia Market Size
-
6.1.5.5 Middle East and Africa Others Market Size
-
-
Only Available with Corporate User License
Chapter 7 Top 10 Countries Analysis (Only Available with Corporate User License)
-
7.1 Country 1 Market Analysis
-
7.1.1 Country 1Prenatal and Newborn Genetic Testing Market Size by Product Type 2019 -2031
-
7.1.2 Country 1Prenatal and Newborn Genetic Testing Market Size by End User 2019 -2031
-
7.1.3 Country 1Prenatal and Newborn Genetic Testing Market Size by Screening 2019 -2031
-
7.1.4 Country 1Prenatal and Newborn Genetic Testing Market Size by Disease 2019 -2031
-
-
7.2 Country 2 Market Analysis
-
7.2.1 Segmentation Analysis will be provided as shown for Country 1
-
-
7.3 Country 3 Market Analysis
-
7.3.1 Segmentation Analysis will be provided as shown for Country 1
-
-
7.4 Country 4 Market Analysis
-
7.4.1 Segmentation Analysis will be provided as shown for Country 1
-
-
7.5 Country 5 Market Analysis
-
7.5.1 Segmentation Analysis will be provided as shown for Country 1
-
-
7.6 Country 6 Market Analysis
-
7.6.1 Segmentation Analysis will be provided as shown for Country 1
-
-
7.7 Country 7 Market Analysis
-
7.7.1 Segmentation Analysis will be provided as shown for Country 1
-
-
7.8 Country 8 Market Analysis
-
7.8.1 Segmentation Analysis will be provided as shown for Country 1
-
-
7.9 Country 9 Market Analysis
-
7.9.1 Segmentation Analysis will be provided as shown for Country 1
-
-
7.10 Country 10 Market Analysis
-
7.10.1 Segmentation Analysis will be provided as shown for Country 1
-
This chapter provides an in-depth analysis of the market share among key competitors of Prenatal and Newborn Genetic Testing. The analysis highlights each competitor's position in the market, growth trends, and financial performance, offering insights into competitive dynamics, and emerging players.
Chapter 8 Competitor Analysis (Subject to Data Availability (Private Players))
-
8.1 Top Competitors Analysis
-
8.1.1 Top Players Ranking 2022
-
8.1.2 Global Prenatal and Newborn Genetic Testing Market Revenue and Share by Key Players
(Subject to Data Availability (Private Players))
-
8.1.3 Industry Mergers and Acquisition Analysis
-
8.1.4 New Product Launch Analysis
-
-
8.2 Company Profile (Data Subject to Availability)
-
8.2.1 Roche Diagnostic
Data Subject to Availability as we consider Top competitors and their market share will be delivered.
-
8.2.1.1 Company Basic Information, Manufacturing Base, Sales Area, and Competitors
-
8.2.1.2 Business Overview
-
8.2.1.3 Financials (Subject to data availability)
-
8.2.1.4 Product Types Specification
-
8.2.1.5 Business Strategy
-
8.2.1.6 S.W.O.TAnalysis
-
-
8.2.2 Elitech Group
Data Subject to Availability as we consider Top competitors and their market share will be delivered.
-
8.2.2.1 Company Basic Information, Manufacturing Base, Sales Area, and Competitors
-
8.2.2.2 Business Overview
-
8.2.2.3 Financials (Subject to data availability)
-
8.2.2.4 Product Types Specification
-
8.2.2.5 Business Strategy
-
8.2.2.6 S.W.O.TAnalysis
-
-
8.2.3 Myriad Genetics
Data Subject to Availability as we consider Top competitors and their market share will be delivered.
-
8.2.3.1 Company Basic Information, Manufacturing Base, Sales Area, and Competitors
-
8.2.3.2 Business Overview
-
8.2.3.3 Financials (Subject to data availability)
-
8.2.3.4 Product Types Specification
-
8.2.3.5 Business Strategy
-
8.2.3.6 S.W.O.TAnalysis
-
-
8.2.4 Biocartis
Data Subject to Availability as we consider Top competitors and their market share will be delivered.
-
8.2.4.1 Company Basic Information, Manufacturing Base, Sales Area, and Competitors
-
8.2.4.2 Business Overview
-
8.2.4.3 Financials (Subject to data availability)
-
8.2.4.4 Product Types Specification
-
8.2.4.5 Business Strategy
-
8.2.4.6 S.W.O.TAnalysis
-
-
8.2.5 IntegraGen
Data Subject to Availability as we consider Top competitors and their market share will be delivered.
-
8.2.5.1 Company Basic Information, Manufacturing Base, Sales Area, and Competitors
-
8.2.5.2 Business Overview
-
8.2.5.3 Financials (Subject to data availability)
-
8.2.5.4 Product Types Specification
-
8.2.5.5 Business Strategy
-
8.2.5.6 S.W.O.TAnalysis
-
-
8.2.6 Perkin Elmer
Data Subject to Availability as we consider Top competitors and their market share will be delivered.
-
8.2.6.1 Company Basic Information, Manufacturing Base, Sales Area, and Competitors
-
8.2.6.2 Business Overview
-
8.2.6.3 Financials (Subject to data availability)
-
8.2.6.4 Product Types Specification
-
8.2.6.5 Business Strategy
-
8.2.6.6 S.W.O.TAnalysis
-
-
8.2.7 WaferGen Biosystem
Data Subject to Availability as we consider Top competitors and their market share will be delivered.
-
8.2.7.1 Company Basic Information, Manufacturing Base, Sales Area, and Competitors
-
8.2.7.2 Business Overview
-
8.2.7.3 Financials (Subject to data availability)
-
8.2.7.4 Product Types Specification
-
8.2.7.5 Business Strategy
-
8.2.7.6 S.W.O.TAnalysis
-
-
8.2.8 Interpace Diagnostics
Data Subject to Availability as we consider Top competitors and their market share will be delivered.
-
8.2.8.1 Company Basic Information, Manufacturing Base, Sales Area, and Competitors
-
8.2.8.2 Business Overview
-
8.2.8.3 Financials (Subject to data availability)
-
8.2.8.4 Product Types Specification
-
8.2.8.5 Business Strategy
-
8.2.8.6 S.W.O.TAnalysis
-
-
8.2.9 Quest Diagnostic
Data Subject to Availability as we consider Top competitors and their market share will be delivered.
-
8.2.9.1 Company Basic Information, Manufacturing Base, Sales Area, and Competitors
-
8.2.9.2 Business Overview
-
8.2.9.3 Financials (Subject to data availability)
-
8.2.9.4 Product Types Specification
-
8.2.9.5 Business Strategy
-
8.2.9.6 S.W.O.TAnalysis
-
-
8.2.10 Bio-Rad
Data Subject to Availability as we consider Top competitors and their market share will be delivered.
-
8.2.10.1 Company Basic Information, Manufacturing Base, Sales Area, and Competitors
-
8.2.10.2 Business Overview
-
8.2.10.3 Financials (Subject to data availability)
-
8.2.10.4 Product Types Specification
-
8.2.10.5 Business Strategy
-
8.2.10.6 S.W.O.TAnalysis
-
-
8.2.11 AutoGenomics
Data Subject to Availability as we consider Top competitors and their market share will be delivered.
-
8.2.11.1 Company Basic Information, Manufacturing Base, Sales Area, and Competitors
-
8.2.11.2 Business Overview
-
8.2.11.3 Financials (Subject to data availability)
-
8.2.11.4 Product Types Specification
-
8.2.11.5 Business Strategy
-
8.2.11.6 S.W.O.TAnalysis
-
-
8.2.12 Abbott
Data Subject to Availability as we consider Top competitors and their market share will be delivered.
-
8.2.12.1 Company Basic Information, Manufacturing Base, Sales Area, and Competitors
-
8.2.12.2 Business Overview
-
8.2.12.3 Financials (Subject to data availability)
-
8.2.12.4 Product Types Specification
-
8.2.12.5 Business Strategy
-
8.2.12.6 S.W.O.TAnalysis
-
-
8.2.13 Cepheid
Data Subject to Availability as we consider Top competitors and their market share will be delivered.
-
8.2.13.1 Company Basic Information, Manufacturing Base, Sales Area, and Competitors
-
8.2.13.2 Business Overview
-
8.2.13.3 Financials (Subject to data availability)
-
8.2.13.4 Product Types Specification
-
8.2.13.5 Business Strategy
-
8.2.13.6 S.W.O.TAnalysis
-
-
8.2.14 EKF Diagnostics
Data Subject to Availability as we consider Top competitors and their market share will be delivered.
-
8.2.14.1 Company Basic Information, Manufacturing Base, Sales Area, and Competitors
-
8.2.14.2 Business Overview
-
8.2.14.3 Financials (Subject to data availability)
-
8.2.14.4 Product Types Specification
-
8.2.14.5 Business Strategy
-
8.2.14.6 S.W.O.TAnalysis
-
-
8.2.15 Natera
Data Subject to Availability as we consider Top competitors and their market share will be delivered.
-
8.2.15.1 Company Basic Information, Manufacturing Base, Sales Area, and Competitors
-
8.2.15.2 Business Overview
-
8.2.15.3 Financials (Subject to data availability)
-
8.2.15.4 Product Types Specification
-
8.2.15.5 Business Strategy
-
8.2.15.6 S.W.O.TAnalysis
-
-
8.2.16 Agilent Technologies
Data Subject to Availability as we consider Top competitors and their market share will be delivered.
-
8.2.16.1 Company Basic Information, Manufacturing Base, Sales Area, and Competitors
-
8.2.16.2 Business Overview
-
8.2.16.3 Financials (Subject to data availability)
-
8.2.16.4 Product Types Specification
-
8.2.16.5 Business Strategy
-
8.2.16.6 S.W.O.TAnalysis
-
-
8.2.17 Illumina
Data Subject to Availability as we consider Top competitors and their market share will be delivered.
-
8.2.17.1 Company Basic Information, Manufacturing Base, Sales Area, and Competitors
-
8.2.17.2 Business Overview
-
8.2.17.3 Financials (Subject to data availability)
-
8.2.17.4 Product Types Specification
-
8.2.17.5 Business Strategy
-
8.2.17.6 S.W.O.TAnalysis
-
-
8.2.18 Ariosa Diagnostics
Data Subject to Availability as we consider Top competitors and their market share will be delivered.
-
8.2.18.1 Company Basic Information, Manufacturing Base, Sales Area, and Competitors
-
8.2.18.2 Business Overview
-
8.2.18.3 Financials (Subject to data availability)
-
8.2.18.4 Product Types Specification
-
8.2.18.5 Business Strategy
-
8.2.18.6 S.W.O.TAnalysis
-
-
8.2.19 Sequenom
Data Subject to Availability as we consider Top competitors and their market share will be delivered.
-
8.2.19.1 Company Basic Information, Manufacturing Base, Sales Area, and Competitors
-
8.2.19.2 Business Overview
-
8.2.19.3 Financials (Subject to data availability)
-
8.2.19.4 Product Types Specification
-
8.2.19.5 Business Strategy
-
8.2.19.6 S.W.O.TAnalysis
-
-
This chapter would comprehensively cover market drivers, trends, restraints, opportunities, and various in-depth analyses like industrial chain, PESTEL, Porter’s Five Forces, and ESG, among others. It would also include product life cycle, technological advancements, and patent insights.
Chapter 9 Qualitative Analysis (Subject to Data Availability)
-
9.1 Market Drivers
-
9.2 Market Restraints
-
9.3 Market Trends
-
9.4 Market Opportunity
-
9.5 Technological Road Map (Subject to Data Availability)
-
9.6 Product Life Cycle (Subject to Data Availability)
-
9.7 Consumer Preference Analysis
-
9.8 Market Attractiveness Analysis
-
9.9 PESTEL Analysis
-
9.9.1 Political Factors
-
9.9.2 Economic Factors
-
9.9.3 Social Factors
-
9.9.4 Technological Factors
-
9.9.5 Legal Factors
-
9.9.6 Environmental Factors
-
-
9.10 Industrial Chain Analysis (Subject to Data Availability)
-
9.10.1 Industry Chain Analysis
-
9.10.2 Manufacturing Cost Analysis
-
9.10.3 Supply Side Analysis
-
9.10.3.1 Raw Material Analysis
-
9.10.3.2 Raw Material Procurement Analysis
-
9.10.3.3 Raw Material Price Trend Analysis
-
-
-
9.11 Porter’s Five Forces Analysis
-
9.11.1 Bargaining Power of Suppliers
-
9.11.2 Bargaining Power of Buyers
-
9.11.3 Threat of New Entrants
-
9.11.4 Threat of Substitutes
-
9.11.5 Degree of Competition
-
-
9.12 Patent Analysis (Subject to Data Availability)
-
9.13 ESG Analysis
Segmentation Product Type Analysis 2019 -2031, will provide market size split by Product Type. This Information is provided at Global Level, Regional Level and Top Countries Level The report with the segmentation perspective mentioned under this chapters will be delivered to you On Demand. So please let us know if you would like to receive this additional data as well. No additional cost will be applicable for the same.
Chapter 10 Market Split by Product Type Analysis 2019 -2031
-
10.1 Consumables
-
10.1.1 Global Prenatal and Newborn Genetic Testing Revenue Market Size and Share by Consumables 2019 -2031
-
-
10.2 Instruments
-
10.2.1 Global Prenatal and Newborn Genetic Testing Revenue Market Size and Share by Instruments 2019 -2031
-
The report with the segmentation perspective mentioned under this chapters will be delivered to you On Demand. So please let us know if you would like to receive this additional data as well. No additional cost will be applicable for the same.
Chapter 11 Market Split by End User Analysis 2019 -2031
-
11.1 Hospitals
-
11.1.1 Global Prenatal and Newborn Genetic Testing Revenue Market Size and Share by Hospitals 2019 - 2031
-
-
11.2 Diagnostic Organization
-
11.2.1 Global Prenatal and Newborn Genetic Testing Revenue Market Size and Share by Diagnostic Organization 2019 - 2031
-
-
11.3 Maternity and Specialty Clinics
-
11.3.1 Global Prenatal and Newborn Genetic Testing Revenue Market Size and Share by Maternity and Specialty Clinics 2019 - 2031
-
-
11.4 Other
-
11.4.1 Global Prenatal and Newborn Genetic Testing Revenue Market Size and Share by Other 2019 - 2031
-
The report with the segmentation perspective mentioned under this chapters will be delivered to you On Demand. So please let us know if you would like to receive this additional data as well. No additional cost will be applicable for the same.
Chapter 12 Market Split by Screening Analysis 2019 -2031
-
12.1 Non-invasive Prenatal Testing
-
12.1.1 Global Prenatal and Newborn Genetic Testing Revenue Market Size and Share by Non-invasive Prenatal Testing 2019 -2031
-
-
12.2 Chronic Villus Sampling
-
12.2.1 Global Prenatal and Newborn Genetic Testing Revenue Market Size and Share by Chronic Villus Sampling 2019 -2031
-
-
12.3 Amniocentesis
-
12.3.1 Global Prenatal and Newborn Genetic Testing Revenue Market Size and Share by Amniocentesis 2019 -2031
-
-
12.4 Maternal Serum Screening
-
12.4.1 Global Prenatal and Newborn Genetic Testing Revenue Market Size and Share by Maternal Serum Screening 2019 -2031
-
-
12.5 Others
-
12.5.1 Global Prenatal and Newborn Genetic Testing Revenue Market Size and Share by Others 2019 -2031
-
The report with the segmentation perspective mentioned under this chapters will be delivered to you On Demand. So please let us know if you would like to receive this additional data as well. No additional cost will be applicable for the same.
Chapter 13 Market Split by Disease Analysis 2019 -2031
-
13.1 Downs Syndrome
-
13.1.1 Global Prenatal and Newborn Genetic Testing Revenue Market Size and Share by Downs Syndrome 2019 -2031
-
-
13.2 Phenylketonuria
-
13.2.1 Global Prenatal and Newborn Genetic Testing Revenue Market Size and Share by Phenylketonuria 2019 -2031
-
-
13.3 Cystic Fibrosis
-
13.3.1 Global Prenatal and Newborn Genetic Testing Revenue Market Size and Share by Cystic Fibrosis 2019 -2031
-
-
13.4 Sickle Cell Anemia
-
13.4.1 Global Prenatal and Newborn Genetic Testing Revenue Market Size and Share by Sickle Cell Anemia 2019 -2031
-
-
13.5 Others
-
13.5.1 Global Prenatal and Newborn Genetic Testing Revenue Market Size and Share by Others 2019 -2031
-
This chapter helps you understand the Key Takeaways and Analyst Point of View of the global Prenatal and Newborn Genetic Testing market
Chapter 14 Research Findings
-
14.1 Key Takeaways
-
14.2 Analyst Point of View
Here the analyst will summarize the content of entire report and will share his view point on the current industry scenario and how the market is expected to perform in the near future. The points shared by the analyst are based on his/her detailed in-depth understanding of the market during the course of this report study. You will be provided exclusive rights to interact with the concerned analyst for unlimited time pre purchase as well as post purchase of the report.
-
14.3 Assumptions and Acronyms
Sample Format of Deliverables
The Tables, Graphs/Charts are only for representative purposes and do not depict actual statistics. Purchase full Report access to actual data.
Qualitative Analysis
Research Methodology Implemented by Manjiri Kanhere and Team
- 1.1 Prenatal and Newborn Genetic Testing Market Report 2024 Research Methodology
- 1.2 Systematic Research Approach
- 1.2.1 Primary Research for Prenatal and Newborn Genetic Testing Market
- 1.2.1.1 Key Data from Primary
- 1.2.1.2 Primary Interviews with Experts
- 1.2.1.3 Key Industry Insights
- 1.2.1.4 Questionnaire for Prenatal and Newborn Genetic Testing Market
- 1.2.1.5 Breakdown of Primaries
- 1.2.2 Secondary Research for Prenatal and Newborn Genetic Testing Market
- 1.2.2.1 Key Data from Secondary
- 1.2.2.2 Paid Sources
- 1.2.2.3 Public Sources
- 1.3 Market Size Estimation for Prenatal and Newborn Genetic Testing Market
- 1.3.1 Top-Down Approach
- 1.3.1.1 Analyzing Market Size by Top-Down Approach (Supply Side)
- 1.3.2 Bottom-UP Approach
- 1.3.2.1 Analyzing Market Size by Bottom-Up Approach (Demand Side)
- 1.3.1 Top-Down Approach
- 1.4 Market Breakdown and Data Triangulation
- 1.5 Research Assumptions for Prenatal and Newborn Genetic Testing Market
Key Questions Answered By Prenatal and Newborn Genetic Testing Market Report 2024
| Why Consumables have a significant impact on Prenatal and Newborn Genetic Testing market? |
| What are the key factors affecting the Consumables and Instruments of Prenatal and Newborn Genetic Testing Market? |
| What is the CAGR/Growth Rate of Hospitals during the forecast period? |
| By type, which segment accounted for largest share of the global Prenatal and Newborn Genetic Testing Market? |
| Which region is expected to dominate the global Prenatal and Newborn Genetic Testing Market within the forecast period? |
| Segmentation Level Customization |
|
| Global level Data Customization |
|
| Region level Data Customization |
|
| Country level Data Customization |
|
| Company Level |
|
| Additional Data Analysis |
|
| Additional Qualitative Data |
|
| Additional Quantitative Data |
|
| Service Level Customization |
|
Report Format Alteration |
|
